ANW:FRA
Immuron Ltd
0,030 €
0,00%
(0,00) 1J
12 oct., 08:05:52 UTC+2 · EUR
search
Tous les symboles
| Symbole | Cours | Variation | % variat. |
|---|
insights_autoGénération des principaux insights pour ANW...
Cap. boursière
12,20 M
Vol. moyen
627,00
Volume
0,00
+ haut sur 1 an
0,04 €
+ bas sur 1 an
0,01 €
Nombre d'employés
8
Cap. boursière
12,20 M
Vol. moyen
627,00
Volume
0,00
+ haut sur 1 an
0,04 €
+ bas sur 1 an
0,01 €
Nombre d'employés
8
Articles
Sources : Web et partenaires du secteur de l'information
TipRanks
·
il y a 6 heures
Immuron advances Travelan after Phase 2 data published in Nature journal
https://www.dars.gov.et/
·
il y a 1 semaine
Immuron (IMRN) Slips 1.83% to $1.07 as Shares Drift Toward Lower Support - MA Cross Alert
Profil
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
À propos de Immuron Ltd
PDG-
Employés8
Date de création1994
Siège socialBlackburn North, Victoria, Australie
Secteur-
Site Webimmuron.com.au